REMY BIOSCIENCES BIODERMAL TECHNOLOGY Trademark
Trademark Overview
On Thursday, September 22, 2022, a trademark application was filed for REMY BIOSCIENCES BIODERMAL TECHNOLOGY with the United States Patent and Trademark Office. The USPTO has given the REMY BIOSCIENCES BIODERMAL TECHNOLOGY trademark a serial number of 97603139. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, January 22, 2024. This trademark is owned by REMY Biosciences, Inc.. The REMY BIOSCIENCES BIODERMAL TECHNOLOGY trademark is filed in the Pharmaceutical Products category with the following description:
Medicinal preparations for the delivery of molecules and compounds transdermally, through the dermal or skin layer, and orally through sublingual tablets that deliver molecules through mucosal pathways, under the tongue, via innovative medical products and therapies to treat a wide variety of ailments and health conditions
General Information
| Serial Number | 97603139 |
| Word Mark | REMY BIOSCIENCES BIODERMAL TECHNOLOGY |
| Filing Date | Thursday, September 22, 2022 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Monday, January 22, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Description of Mark | The mark consists of The design mark consists of a six sided cube with only 3 sides visible. The cube consists of equally spaced blue dots having a double row of larger bolded dots located on both the left and right of the cube sides. The literal element consists of the words - remy biosciences biodermal technology - in blue and only having non capital letters and a larger bolded font for the word remy. |
| Goods and Services | Medicinal preparations for the delivery of molecules and compounds transdermally, through the dermal or skin layer, and orally through sublingual tablets that deliver molecules through mucosal pathways, under the tongue, via innovative medical products and therapies to treat a wide variety of ailments and health conditions |
| Indication of Colors claimed | The color(s) blue is/are claimed as a feature of the mark. |
| Disclaimer with Predetermined Text | "BIOSCIENCES" AND "TECHNOLOGY" |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, October 11, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | REMY Biosciences, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Newport Coast, CA 92657 |
Trademark Events
| Event Date | Event Description |
| Monday, January 22, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, January 22, 2024 | NON-FINAL ACTION E-MAILED |
| Monday, January 22, 2024 | NON-FINAL ACTION WRITTEN |
| Thursday, December 21, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, December 20, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, December 20, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, September 20, 2023 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Wednesday, September 20, 2023 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Tuesday, June 20, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, June 20, 2023 | NON-FINAL ACTION E-MAILED |
| Tuesday, June 20, 2023 | NON-FINAL ACTION WRITTEN |
| Wednesday, June 7, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, October 12, 2022 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Tuesday, October 11, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, September 26, 2022 | NEW APPLICATION ENTERED |
